Celanese (CE) Q4 2005 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2005 earnings summary
10 Nov, 2026Executive summary
FY 2005 revenue was $6.07bn, operating profit $561m and net earnings $277m; basic and diluted EPS were $1.73 and $1.67.
Higher pricing and productivity gains supported results, while raw-material and energy inflation, acquisition integration costs and high debt remained significant factors.
Operating cash flow was $714m; year-end cash was $390m, total debt $3.437bn and net debt $3.047bn.
Financial highlights
Gross margin was $1.297bn; SG&A was $562m and R&D was $91m for FY 2005.
Cash from operations of $714m included benefits from higher earnings, lower pension contributions and improved receivables turnover.
FY 2005 effective tax rate was 16%; a $31m reversal of valuation allowance on certain German deferred tax assets contributed to the lower rate.
Reported results included a $36m transportation antitrust settlement recorded as a reduction to cost of sales, a $23m property-sale gain, a $35m COC disposal loss and $34m of plumbing insurance recoveries.
Outlook and guidance
A 600,000-metric-ton/year acetic acid plant at Nanjing, alongside planned VAM and emulsions units, targeted startup in H1 2007.
A new Asian GUR plant was planned to begin production in H2 2007; Vantage Plus technology was intended to improve efficiency and reduce operating costs across the manufacturing network.
U.S. air regulations were expected to add $35m-$45m in compliance costs through 2007; an adverse court outcome could add an estimated $50m.
Management expected continued investment in growth capacity, cost reduction and productivity, while noting that capital spending remained below depreciation.
Latest events from Celanese
- Sales and operating profit grew, but financing costs and restructuring drove a $253 million loss.CE
Q4 2004 - Pricing and productivity lifted FY 2006 operating profit 30.3% to $747M.CE
Q4 2006 - Pricing and currency lifted sales 12%, while outages, costs and refinancing weighed on results.CE
Q4 2007 - Recession cut earnings, but cash improved and recovery was expected in 2010.CE
Q4 2009 - Recovery lifted sales and operating profit; 2011 growth was expected across all segments.CE
Q4 2010 - FY11 earnings grew on pricing and mix, while major capacity and ethanol investments set up the next growth phase.CE
Q4 2011 - Acetyl pricing and currency dragged FY12 results; 12%–14% earnings growth targeted for FY13.CE
Q4 2012 - A $742 million relocation gain drove record reported profit amid mixed segment trends.CE
Q4 2013 - Sales and adjusted EPS advanced as record cash flow funded growth and shareholder returns.CE
Q4 2014